Quick Answer
Core Laboratories Inc. /DE/ reported Diluted EPS of $0.63 per share for fiscal year 2025.
Core Laboratories Inc. /DE/ Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.63 | -4.5% |
| 2024 | $0.66 | -14.3% |
| 2023 | $0.77 | +83.3% |
| 2022 | $0.42 | +0.0% |
| 2021 | $0.42 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.30 | +20.0% | +36.4% |
| June 30, 2025 | $0.22 | +15.8% | — |
| March 31, 2025 | $0.00 | -100.0% | -100.0% |
| September 30, 2024 | $0.25 | +31.6% | +31.6% |
| June 30, 2024 | $0.19 | -60.4% | +171.4% |
| March 31, 2024 | $0.07 | +40.0% | -63.2% |
| September 30, 2023 | $0.19 | +18.8% | -60.4% |
| June 30, 2023 | $0.48 | +220.0% | +860.0% |
- Core Laboratories Inc. /DE/ showed a decrease of -4.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2021–2025 period, Core Laboratories Inc. /DE/’s diluted eps has grown by 50.0% (from $0.42 per share to $0.63 per share).
- The most recent figure is from Core Laboratories Inc. /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 23, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: